Biblio

Export 188 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Brain  [Clear All Filters]
Journal Article
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., “11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.”, J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
H. Jin Kim, Cho, H., Werring, D. J., Jang, Y. Kyoung, Kim, Y. Jin, San Lee, J., Lee, J., Jun, S., Park, S., Ryu, Y. Hoon, Choi, J. Yong, Cho, Y. Seok, Moon, S. Hwan, Na, D. L., Lyoo, C. Hyoung, and Seo, S. Won, “18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 3, pp. 711-716, 2017.
M. T. Fodero-Tavoletti, Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., Gong, S., Adlard, P. A., Barnham, K. J., Rowe, C. C., Masters, C. L., Kudo, Y., Cappai, R., Yanai, K., and Villemagne, V. L., “18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.”, Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
L. Ni, Liu, R., Yin, Z., Zhao, H., Nedelska, Z., Hort, J., Zhou, F., Wu, W., Zhang, X., Li, M., Yu, H., Zhu, B., Xu, Y., and Zhang, B., “Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and concomitant Lacunar Infarction: A Resting-State Functional MRI Study.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1243-54, 2016.
W. H. Bouvy, Kuijf, H. J., Zwanenburg, J. J. M., Koek, H. L., L Kappelle, J., Luijten, P. R., M Ikram, K., and Biessels, G. Jan, “Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 705-710, 2017.
J. Dukart, Sambataro, F., and Bertolino, A., “Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1143-59, 2016.
T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
Y. Shan, Wang, D. - D., Xu, Y. - X., Wang, C., Cao, L., Liu, Y. - S., and Zhu, C. - Q., “Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid.”, J Alzheimers Dis, vol. 49, no. 3, pp. 829-44, 2016.
C. Saraceno, Catania, M., Paterlini, A., Fostinelli, S., Ciani, M., Zanardini, R., Binetti, G., Di Fede, G., Caroppo, P., Benussi, L., Ghidoni, R., and Bolognin, S., “Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1477-1483, 2018.
U. Rüb, Stratmann, K., Heinsen, H., Seidel, K., Bouzrou, M., and Korf, H. - W., “Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.”, J Alzheimers Dis, vol. 57, no. 3, pp. 683-696, 2017.
T. G. Beach, Maarouf, C. L., Intorcia, A., Sue, L. I., Serrano, G. E., Lu, M., Joshi, A., Pontecorvo, M. J., and Roher, A. E., “Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., “Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.”, Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
A. Hatami, Monjazeb, S., and Glabe, C., “The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.”, J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
J. Bastrup, Hansen, K. H., Poulsen, T. B. G., Kastaniegaard, K., Asuni, A. A., Christensen, S., Belling, D., Helboe, L., Stensballe, A., and Volbracht, C., “Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 1, pp. 249-265, 2021.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., “Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A., “APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.”, Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., “An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.
N. Kuriyama, Ozaki, E., Mizuno, T., Ihara, M., Mizuno, S., Koyama, T., Matsui, D., Watanabe, I., Akazawa, K., Takeda, K., Takada, A., Inaba, M., Yamada, S., Motoyama, K., Takeshita, W., Iwai, K., Hashiguchi, K., Kobayashi, D., Kondo, M., Tamura, A., Yamada, K., Nakagawa, M., and Watanabe, Y., “Association between α-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI.”, J Alzheimers Dis, vol. 61, no. 1, pp. 145-155, 2018.
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, “Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
I. Karakis, Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G., DeCarli, C., Vasan, R. S., Wang, T. J., Himali, J. J., Annweiler, C., and Seshadri, S., “Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
W. M. A. D. Bino Fernando, Rainey-Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., S Macaulay, L., Brown, B. M., Gupta, V. Bala, Sohrabi, H. R., Weinborn, M., Taddei, K., Laws, S. M., Goozee, K., Ames, D., Fowler, C., Maruff, P., Masters, C. L., Salvado, O., Rowe, C. C., and Martins, R. N., “Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
S. Eketjäll, Janson, J., Kaspersson, K., Bogstedt, A., Jeppsson, F., Fälting, J., Haeberlein, S. Budd, Kugler, A. R., Alexander, R. C., and Cebers, G., “AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1109-23, 2016.
M. J. Andersson and Stone, J., “Best Medicine for Dementia: The Life-Long Defense of the Brain.”, J Alzheimers Dis, vol. 94, no. 1, pp. 51-66, 2023.
P. Caffarra, Ghetti, C., Ruffini, L., Spallazzi, M., Spotti, A., Barocco, F., Guzzo, C., Marchi, M., and Gardini, S., “Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 51, no. 1, pp. 27-31, 2016.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., “Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.

Pages